ArticleFrontiers in pediatrics2026
Transcriptomic identification of IL-17/FOS-associated signaling in dartos fascia remodeling of pediatric concealed penis.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pediatric concealed penis (CP) is a congenital penile anomaly that has been associated with abnormal dartos fascia development, reduced tissue compliance, and fibrotic remodeling. While surgical correction is standard, the molecular etiology of this pathological fibrosis remains largely unexplored. This study aims to delineate the transcriptomic landscape of CP and identify candidate signaling pathways associated with dartos fascia remodeling. We performed RNA-seq on dartos fascia tissues from CP patients and phimosis control tissues, followed by bioinformatic analysis and validation using qRT-PCR, Western blot, and immunohistochemistry. RNA-seq and functional enrichment analysis identified a significantly enriched IL-17-related signaling signature in CP tissues. Experimental validation showed increased expression of key nodes such as IL-17RA, ACT1, FOS, IL-6, and PTGS2. Notably, synchronous upregulation of FOS and downstream inflammation- and remodeling-associated mediators IL-6 and PTGS2 was accompanied by fragmented elastic fibers and increased matrix deposition. These findings provide preliminary clinical tissue-based evidence that IL-17/FOS-associated inflammatory remodeling signatures are enriched in CP dartos fascia and may contribute to reduced tissue compliance and fibrosis. Further functional studies are required to determine causality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.